School of Medicine
Showing 1-10 of 11 Results
-
Keara E. Valentine
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKeara E. Valentine, Psy.D., is a clinical assistant professor at Stanford University School of Medicine in the Psychosocial Treatment Clinic and OCD Clinic, where she specializes in the assessment and treatment of OCD and related disorders. Dr. Valentine utilizes behavioral-based therapies including Cognitive Behavioral Therapy (CBT) and Exposure and Response Prevention (ERP) with children, adolescents, and adults experiencing anxiety-related disorders.
Dr. Valentine completed an APA accredited pre-doctoral internship at Alexian Brothers Behavioral Health Hospital, where she complete a rotation in OCD and anxiety disorders and a rotation in Eating Disorders. Dr. Valentine has experience working with individuals with OCD, anxiety, and/or eating disorders at various levels of care including outpatient, partial hospitalization, residential, and inpatient. -
Axel Valle, PsyD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Axel Valle is a licensed clinical psychologist providing individual psychotherapy in English and Spanish. He specializes in cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD) and anxiety disorders, with additional expertise in working with high-performance athletes.
Dr. Valle brings a distinctive international clinical background to his practice. He completed his postdoctoral fellowship at Stanford University School of Medicine’s Department of Psychiatry and Behavioral Sciences and earned his doctorate in clinical psychology from The Wright Institute in Berkeley. He also holds a Master’s degree in crisis and trauma from Tel Aviv University and is a licensed clinical psychologist in Mexico City, his place of origin. -
Peter Johannes van Roessel
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Peter van Roessel, MD PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City, with additional training in psychodynamic psychotherapy (TFP) via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University.
At Stanford, Dr. van Roessel sees adult mood and anxiety disorders outpatients through the Assessment Clinics and participates in resident training and patient care as director of the resident Continuity Clinic and as a supervisor in psychodynamic psychotherapy. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology. As a member of the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and contributes to and leads clinical neuroscience studies pioneering rapid-acting interventions in OCD. Clinically motivated research interests include the nature and neural correlates of metacognitive ‘awareness’ (insight) in OCD and related disorders, and particularly the relationship of awareness to mechanisms of attentional control.
Dr. van Roessel pursued research training in basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. He has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he was a 2020-2022 Miller Foundation Fellow, and from 2020 to 2022 was a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA. Dr. van Roessel is a Fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. -
Nina Vasan, MD, MBA
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsAt Brainstorm: The Stanford Lab for Mental Health Innovation, we lead the way in digital well-being: translating cutting-edge research into practical solutions for healthier tech use.
We are first and foremost practicing physicians; we treat patients and families. Then, grounded by the foundational oath in medicine to “do no harm,” we help companies build products that prioritize user health with responsibility and care. Our work has shaped platforms used by millions—helping Pinterest design "compassionate search", guiding TikTok in healthy screen-time management, and partnering with ML Commons to establish the first mental health safety benchmarks for large language models (LLMs).
Brainstorm is further committed to “do good” by leveraging these technologies to build a healthier digital world. We advised Dove’s Self-Esteem Project and Real Beauty Prompt Playbook, which studied AI’s impact on beauty and set new digital standards of representation. Additionally, after sharing the results of research conducted with the Stanford Center for AI Safety on the ethics, efficacy, and safety of LLMs providing mental health support, we developed the “Framework for Healthy AI” to guide industry best practices in AI product innovation.
As we apply this expertise to improve users' daily lives, it’s clear that addressing digital intimacy presents unique challenges compared to traditional human relationships. This technology is still emerging, and we are all adapting to it in real-time as it evolves. The big question is: How can we help users cultivate healthy, safe digital relationships?
After seeing success with the Stanford Social Media Safety Plan, which reduced harmful digital behaviors among users, we are now designing the Stanford GenAI Psychological Safety Plan (GPS). The Stanford GPS is a tool to help individuals, tech developers, and policymakers navigate this new terrain and make informed decisions about AI’s role in mental health.
Check out the start of the Stanford GPS in Fortune: This 4-question quiz from Stanford psychiatrists can help protect from the dangers of AI. -
Mytilee Vemuri
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsI am a Clinical Assistant Professor of Psychiatry, with clinical and research interests in hormonal influences on women’s mental and cognitive health. After Psychiatry residency I completed a NIMH research fellowship studying gender differences in metabolic complications such as dyslipidemia, obesity, and insulin-resistance in patients with bipolar disorder. As a research fellow, I also provided clinical oversight for research participants in studies evaluating hormonal change, metabolic biomarkers and mood. More recently, I have collaborated with PI Duncan and her research group on projects studying relationships between sex hormones and mood/anxiety disorders, particularly in peri-menopausal women. From these experiences I have gained experience in conducting clinical research and collaborating in interdisciplinary research teams. I have also had over 20 years of clinical experience as an attending psychiatrist in Stanford Women’s Wellness psychiatry, general psychiatry and primary care clinics treating a wide range of psychiatric conditions including perimenopausal and geriatric mood disorders. I have published review articles detailing the evidence-basis for treating mood disorders in women during times of hormonal change, and the role of hormones as potential treatments. I also serve as the Stanford Psychiatry Department’s clinical quality improvement leader, where I oversee multiple interdisciplinary improvement teams charged with improving the quality and efficiency of care processes. I currently specialize in managing perimenopausal mood disorders and have an interest in the judicious use of menopausal hormone therapy as an adjunctive treatment for mood symptoms in this population. My clinical and research experience in the intersection of women’s mental health, sex-steroid hormones, and the perimenopause, along with broad experience working on cross-disciplinary teams, will bring valuable input to this research team.
-
Janani Venugopalakrishnan
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsAutism spectrum disorders
